Park National Corp OH Has $229,000 Stock Position in Baxter International Inc. (NYSE:BAX)

Park National Corp OH cut its stake in shares of Baxter International Inc. (NYSE:BAX) by 8.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,864 shares of the medical instruments supplier’s stock after selling 696 shares during the period. Park National Corp OH’s holdings in Baxter International were worth $229,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in BAX. M&R Capital Management Inc. lifted its holdings in Baxter International by 9.5% during the 3rd quarter. M&R Capital Management Inc. now owns 4,480 shares of the medical instruments supplier’s stock worth $170,000 after purchasing an additional 390 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Baxter International by 6.5% during the third quarter. GAMMA Investing LLC now owns 7,517 shares of the medical instruments supplier’s stock worth $285,000 after buying an additional 459 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Baxter International by 23.2% in the third quarter. Farther Finance Advisors LLC now owns 2,519 shares of the medical instruments supplier’s stock valued at $96,000 after acquiring an additional 475 shares during the period. LRI Investments LLC increased its position in Baxter International by 60.8% during the third quarter. LRI Investments LLC now owns 1,560 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 590 shares during the period. Finally, First PREMIER Bank bought a new position in Baxter International during the third quarter worth about $25,000. Institutional investors own 90.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Stifel Nicolaus decreased their target price on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. StockNews.com lowered Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. Finally, Citigroup cut their target price on Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $40.45.

Baxter International Stock Up 0.1 %

Shares of NYSE BAX opened at $29.61 on Thursday. The stock has a 50-day moving average price of $31.83 and a two-hundred day moving average price of $34.86. Baxter International Inc. has a 12 month low of $28.33 and a 12 month high of $44.01. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31. The company has a market cap of $15.12 billion, a price-to-earnings ratio of 148.06, a PEG ratio of 12.74 and a beta of 0.59.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 EPS for the quarter, beating the consensus estimate of $0.78 by $0.02. The business had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.85 billion. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The firm’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.68 EPS. As a group, analysts forecast that Baxter International Inc. will post 1.92 earnings per share for the current fiscal year.

Baxter International Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were given a $0.17 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.68 annualized dividend and a yield of 2.30%. Baxter International’s dividend payout ratio is presently 340.00%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.